Veterinary pharma company spun off from Pfizer.


Updates from The Motley Fool

Latest updates on Zoetis from Fool.com.


Stock Performance

ZTS vs. S&P 500 | 2 Year Performance
View Interactive ZTS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Zoetis.
Current Price: $52.01
Prev Close: $51.02
Open: $51.14
Bid: $50.67
Ask: $52.59
Day's Range: $50.95 - $52.12
52wk Range: $38.26 - $52.64
Volume: 3,971,569
Avg Vol 3,399,072
Market Cap: $26B
P/E (ttm): 39.55
EPS (ttm): $1.29
Div & Yield: $0.38 (0.7%)

Company Rating

What our community thinks about Zoetis.
CAPS Rating 4 out of 5
 
118 Outperform
5 Underperform
CAPS All Stars
 
29 Outperform
0 Underperform

How do you think Zoetis will perform against the market?



You pick for Zoetis is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Juan Ramon Alaix, CEO

63% Approve

Based on 56 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Zoetis.

Veterinary pharma company spun off from Pfizer.

  • Exchange: NYSE